A patient with newly diagnosed gastric adenocarcinoma presents with anemia and hypoalbuminemia. Which nursing intervention is most appropriate to address the patient's nutritional deficits associated with his condition?

C) Arrange for a consult with a dietitian to develop a tailored nutritional support plan.

A) Encourage the patient to increase oral intake of high-calorie, high-protein snacks.

B) Recommend the patient to follow a low-residue diet to reduce gastrointestinal symptoms.

C) Arrange for a consult with a dietitian to develop a tailored nutritional support plan.

D) Advise the patient to limit fluid intake to prevent abdominal distention.

A patient diagnosed with gastric adenocarcinoma presents with anemia, hypoalbuminemia, and elevated carcinoembryonic antigen (CEA) levels. Considering the patient's current condition and ongoing symptoms, which nursing intervention is most appropriate to address the patient's nutritional status?

B) Encourage small, frequent meals high in protein and calories

A) Administer iron supplements to improve anemia

B) Encourage small, frequent meals high in protein and calories

C) Initiate parenteral nutrition to meet caloric needs

D) Collaborate with a dietitian to develop a low-fiber diet plan

A patient with an ulcerated gastric tumor presents with increased fatigue, dizziness, and nausea. Laboratory tests reveal anemia, electrolyte imbalances, and decreased albumin levels. Which nursing intervention should be prioritized to address the patient's current condition?

B) Initiate intravenous fluid therapy to address dehydration and electrolyte imbalances.

A) Administer anti-nausea medication to improve the patient's appetite.

B) Initiate intravenous fluid therapy to address dehydration and electrolyte imbalances.

C) Provide oral iron supplementation to increase hemoglobin levels.

D) Encourage the patient to eat small, frequent meals to improve nutritional status.

A patient with a history of ulcerated gastric tumor and recent symptoms of increased fatigue, dizziness, and nausea is admitted for anemia, dehydration, and malnutrition. Which nursing intervention is most critical to implement first upon admission?

B) Initiate a blood transfusion to manage anemia.

C) Consult with a dietitian to plan nutritional support.

D) Monitor the patient's vital signs for stability.

A patient with anemia and dehydration has shown initial stabilization with intravenous fluids and blood transfusion. Despite antiemetic therapy, the patient continues to experience nausea, and now exhibits abdominal discomfort and bloating. What should be the nurse's priority action in managing this patient's care?

D) Consult with the dietitian for initiating enteral nutrition via nasogastric tube

A) Administer an additional dose of antiemetic medication as prescribed

B) Encourage the patient to increase oral fluid intake

C) Prepare the patient for an abdominal CT scan as ordered

D) Consult with the dietitian for initiating enteral nutrition via nasogastric tube

A patient has been hospitalized for treatment of anemia and dehydration but is now experiencing persistent nausea and signs of abdominal discomfort, raising concerns about gastrointestinal complications. Despite initial stabilization of vital signs, the patient has ongoing nutritional deficits. What is the nurse's priority intervention at this time?

B) Collaborate with the healthcare team to initiate enteral nutrition via a nasogastric tube.

A) Administer an additional dose of antiemetic medication to address the nausea.

B) Collaborate with the healthcare team to initiate enteral nutrition via a nasogastric tube.

C) Increase the rate of intravenous fluids to improve hydration status.

D) Encourage the patient to increase oral fluid intake despite nausea.

A patient with a partial gastric outlet obstruction due to tumor progression is receiving enteral nutrition via a nasogastric tube. The patient develops a low-grade fever and elevated white blood cell count. What is the most appropriate initial nursing intervention to address the suspected infection?

D) Assess the nasogastric tube insertion site for signs of infection

A) Increase the frequency of vital signs monitoring

B) Flush the nasogastric tube with sterile water regularly

C) Notify the healthcare provider to discontinue enteral feeding

D) Assess the nasogastric tube insertion site for signs of infection

A patient with a partial gastric outlet obstruction due to tumor progression has developed a low-grade fever and elevated white blood cell count. Which nursing intervention is the most appropriate to address the potential infection and ensure patient safety?

B) Ensure the nasogastric tube is properly secured and perform regular oral care.

A) Increase the rate of enteral feeding to enhance nutritional support.

B) Ensure the nasogastric tube is properly secured and perform regular oral care.

C) Discontinue the proton pump inhibitor to assess its impact on gastric acid secretion.

D) Encourage the patient to ambulate frequently to promote gastric motility.

A patient undergoing cancer treatment is experiencing persistent low-grade fever, elevated heart rate, and slight respiratory distress with diminished breath sounds at the right lung base. Given the current symptoms and laboratory findings, what is the priority nursing intervention to address the patient's respiratory status?

B) Encourage frequent use of incentive spirometry and assist with mobilization.

A) Administer prescribed antipyretics to reduce fever.

B) Encourage frequent use of incentive spirometry and assist with mobilization.

C) Increase the patient's oxygen flow rate to improve saturation levels.

D) Prepare the patient for an immediate thoracentesis procedure.

A patient undergoing treatment for cancer has developed a low-grade fever, elevated heart rate, and diminished breath sounds at the right lung base. Laboratory results show an elevated white blood cell count and C-reactive protein. What is the priority nursing intervention for this patient to prevent further respiratory complications?

A) Increase the frequency of incentive spirometry use

B) Administer antipyretics to control fever

C) Encourage the patient to rest in bed to conserve energy

D) Initiate oxygen therapy to address shortness of breath

gastric/intestinal cancer - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic inflammation, often due to Helicobacter pylori infection or dietary carcinogens, leads to DNA damage in gastric/intestinal epithelial cells. This promotes mutations in oncogenes and tumor suppressor genes, triggering uncontrolled cell proliferation.

• Secondary mechanism: Loss of function in tumor suppressor genes such as TP53 disrupts normal cell cycle control and apoptosis. This allows abnormal cells to survive and accumulate, further progressing toward malignancy.

• Key complication: Tumor growth can lead to obstruction or perforation of the gastrointestinal tract, causing symptoms such as nausea, vomiting, and severe pain, and may result in life-threatening complications like peritonitis or metastasis if left untreated.

Patient Profile

Demographics:

62-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, chronic gastritis

• Current medications: Metformin, Lisinopril, Omeprazole

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent abdominal pain and unintentional weight loss

• Key symptoms: Nausea, vomiting, intermittent diarrhea, fatigue, early satiety

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 99.1°F, oxygen saturation 95% on room air

Section 1

New Diagnostic Results:

Following the initial presentation, the medical team decided to conduct a series of diagnostic tests to further investigate the cause of the patient's symptoms. An upper gastrointestinal endoscopy revealed a large ulcerated mass in the antrum of the stomach, prompting biopsies for histopathological analysis. The biopsy results confirmed the presence of adenocarcinoma, a common type of gastric cancer. In addition to endoscopy, a contrast-enhanced CT scan of the abdomen was performed, which showed localized thickening of the gastric wall with no obvious signs of distant metastasis, although there was some regional lymphadenopathy suggesting potential lymphatic involvement.

Laboratory tests revealed anemia with a hemoglobin level of 9.8 g/dL, indicating a possible chronic blood loss associated with the ulcerated tumor. The complete metabolic panel showed hypoalbuminemia, likely due to the patient's poor nutritional status and ongoing weight loss. Tumor markers, including carcinoembryonic antigen (CEA), were elevated, providing further evidence of malignant activity. Liver function tests remained within normal ranges, providing some reassurance that hepatic metastasis had not yet occurred.

These findings underscore the complexity of the patient's condition and suggest that while the cancer appears localized at present, the involvement of lymph nodes raises concerns about potential spread. The multidisciplinary team, including oncologists, gastroenterologists, and surgeons, will need to collaborate closely to develop an appropriate treatment plan, which may involve surgical resection, chemotherapy, or a combination of modalities. The patient will also require supportive care to manage anemia, nutritional deficits, and glycemic control, given his coexisting diabetes. The next steps will involve discussing treatment options with the patient and his family, considering both the potential benefits and risks of each approach in the context of his overall health status.

Section 2

As the patient progresses through their treatment journey, a new complication arises, prompting the care team to reassess and adjust the management plan. During a routine follow-up appointment, the patient reports increased fatigue, intermittent episodes of dizziness, and a noticeable decrease in appetite, which he attributes to persistent nausea. Vital signs reveal a blood pressure of 100/60 mmHg, heart rate of 110 beats per minute, and respiratory rate of 22 breaths per minute. The patient’s weight has decreased by an additional 5 pounds over the past two weeks. Given these symptoms, the medical team becomes concerned about the potential exacerbation of anemia and possible dehydration.

Laboratory tests indicate a further drop in hemoglobin levels to 8.5 g/dL, suggesting ongoing blood loss, likely from the ulcerated gastric tumor. Serum electrolytes reveal mild hyponatremia and hypokalemia, indicating possible electrolyte imbalances due to decreased oral intake and gastrointestinal losses. The patient’s albumin level has also decreased further to 2.8 g/dL, reflecting worsening nutritional status. These laboratory findings, combined with the patient's symptoms, suggest the development of moderate complications requiring immediate attention.

In response to these developments, the multidisciplinary team decides to admit the patient for inpatient management. The plan involves the initiation of intravenous fluids to address dehydration and electrolyte imbalances, as well as a blood transfusion to manage severe anemia. Nutritional support will be intensified, with the consultation of a dietitian to explore supplemental feeding options that could improve the patient's overall nutritional status. These interventions aim to stabilize the patient's condition and optimize his strength in preparation for potential surgical intervention or the commencement of chemotherapy. The team will continue to closely monitor the patient's response to these interventions, adjusting the care plan as necessary to ensure the best possible outcomes.

Section 3

Following the initiation of treatment, the patient's response is closely monitored by the multidisciplinary team. Over the first 48 hours of hospitalization, the patient receives intravenous fluids and a unit of packed red blood cells, resulting in a temporary stabilization of his vital signs. His blood pressure rises to 110/70 mmHg, and heart rate decreases to 95 beats per minute, indicating an initial positive response to the interventions aimed at correcting anemia and dehydration. However, the patient continues to report persistent nausea despite receiving antiemetic medications, which complicates efforts to improve his oral intake.

Repeat laboratory tests reveal a slight improvement in hemoglobin levels, now at 9.2 g/dL, but the patient's albumin remains low at 2.9 g/dL, indicating ongoing nutritional deficits. Electrolyte levels show marginal improvement; however, mild hyponatremia persists. Despite these interventions, the patient begins to exhibit signs of abdominal discomfort and bloating, raising concerns about potential gastrointestinal obstruction or delayed gastric emptying, a complication that could further hinder nutritional intake and exacerbate his condition.

In light of these findings, the care team reevaluates the management plan, considering the possibility of introducing enteral nutrition via a nasogastric tube to bypass gastrointestinal limitations and ensure adequate caloric intake. Additionally, the team contemplates ordering an abdominal CT scan to evaluate for any structural changes or obstructions that could be contributing to the patient's symptoms. These steps are crucial in addressing the patient's current complications and preparing for any necessary surgical interventions or adjustments in his cancer treatment regimen. The team's goal is to maintain a proactive stance, ensuring all aspects of the patient's care are optimized to improve his quality of life and treatment outcomes.

Section 4

As the care team proceeds with the management plan, an abdominal CT scan is conducted to investigate the cause of the patient's persistent nausea and abdominal discomfort. The imaging reveals a partial gastric outlet obstruction, likely due to tumor progression. This finding necessitates a reevaluation of the patient's current treatment strategy, as the obstruction could significantly impact his ability to maintain adequate nutrition and hydration. The obstruction is causing delayed gastric emptying, which aligns with the patient's symptoms of nausea and bloating.

In response to these findings, the multidisciplinary team decides to initiate enteral nutrition via a nasogastric tube to ensure the patient receives adequate caloric and nutritional support. The tube is carefully placed, and an enteral feeding regimen is started, closely monitoring for any signs of intolerance. Additionally, the medical team considers adjusting the patient's antiemetic regimen to better manage his symptoms and improve his comfort level. The patient is also started on a proton pump inhibitor to reduce gastric acid secretion, which may help alleviate irritation at the obstruction site.

Despite these interventions, the patient develops a new complication: a low-grade fever of 100.8°F, along with an increase in his white blood cell count to 13,000/mm³. These changes raise concerns about a potential infection, possibly related to the nasogastric tube or secondary to the gastric outlet obstruction. The care team promptly initiates a workup to identify the source of the infection, including blood cultures and a chest X-ray, while empirically starting broad-spectrum antibiotics to address any possible infectious process. The team remains vigilant, balancing the management of the patient's cancer treatment with the need to address these emerging complications effectively.

Section 5

As the clinical team continues to monitor the patient, they notice subtle changes in his overall status. The patient's fever persists at a low-grade level, hovering around 100.8°F despite the initiation of broad-spectrum antibiotics. His heart rate remains elevated at 102 beats per minute, which is slightly above his baseline, and his blood pressure is stable at 122/78 mmHg. The patient reports feeling increasingly fatigued and slightly more short of breath than usual, prompting the team to reassess his respiratory status. Auscultation of the lungs reveals diminished breath sounds at the right lung base, raising suspicion for a developing pleural effusion or atelectasis, possibly related to decreased mobility or the underlying disease process.

Laboratory results further complicate the clinical picture. The white blood cell count has risen slightly to 14,200/mm³, suggesting a persistent inflammatory or infectious process. C-reactive protein levels are elevated at 12 mg/L, further indicating systemic inflammation. The blood cultures are pending, but the team is cautious about the potential for a resistant organism or a secondary infection due to the patient's immunocompromised state from cancer treatment. A repeat abdominal CT scan is considered to evaluate for any progression of the obstruction or new issues such as an abscess formation.

In response to these findings, the team implements additional interventions. Respiratory therapy is consulted to initiate incentive spirometry to improve lung expansion and prevent atelectasis. The patient is encouraged to mobilize more frequently with assistance to enhance respiratory function and circulation. The nutritionist is engaged to reassess the enteral feeding plan, ensuring optimal support in light of the patient's increased metabolic demands due to infection. As the team awaits further diagnostic results, they remain vigilant and prepared to adjust the treatment plan to address these new challenges, emphasizing a comprehensive approach to the patient's complex needs.